In AD/Fn models, the CD4+ and CD8+ T cells in NM@PLGA‐MTI‐OXA group were ≈2.43‐fold and ≈2.69‐fold of that in Fn group, suggesting an up‐regulation of tumor immunity (Figure S25E–G, Supporting Information). The gene discussed is CD4; the disease is neoplasm.